Showing posts with label Heparin. Show all posts
Showing posts with label Heparin. Show all posts

Tuesday, 12 February 2019

Global Heparin Market Thriving with the analysis of Top Players - Sanofi, Pfizer, Inc., LEO Pharma A/S, Aspen, Baxter International Inc. and B. Braun Melsungen AG

Researchmoz added Most up-to-date research on "Global Heparin Market Thriving with the analysis of Top Players - Sanofi, Pfizer, Inc., LEO Pharma A/S, Aspen, Baxter International Inc. and B. Braun Melsungen AG" to its huge collection of research reports.

Heparin is an anticoagulant that is mainly used to prevent and treat pulmonary embolism, venous thrombosis, and other conditions of blood clotting.  Venous thromboembolism (VTE), including deep venous thrombosis (DVT) and pulmonary embolism (PE), is an important preventable cause of morbidity and mortality among surgical patients.
Key applications of heparin include prevention of blood clotting during dialysis, treatment of pulmonary embolism and deep vein thrombosis, and unwanted blood clotting during open-heart surgery. Heparin is the foremost clinical anticoagulant with more than 500 million doses consumed globally each year. Heparin and related molecules exhibit a large number of newly discovered biological activities with optimum therapeutic potential. Advantages of heparin such as immediate onset of action, short half-life, simple laboratory monitoring, ability to be reversed (protamine), and low cost have led to its broad use.
Global Heparin Market: Scope of Study
A detailed overview of market dynamics, including the drivers, restraints, and opportunities of the heparin market, along with porter’s analysis, major brand analysis, and market strategies adopted by top players of the global heparin market, has been provided in this report. Market revenue as well as volume analysis for all the above mentioned segments has been provided for the forecast period of 2017-2025, considering 2016 as the base year, and 2015 as the historical year, along with compound annual growth rate (CAGR %), for the forecast period of 2017-2025. Market share estimations were based on in-depth analysis and study of products, and their features etc.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=160096

This report provides in-depth analysis value and volume of the heparin market. The stakeholders for this report include companies involved in the manufacturing of heparin. Executive summary section is included snapshot on stakeholders in this report, which summarizes the market size, trends and competition in different regions. Market players and market share analysis is analyzed to signify percentage share of the major players operating in the heparin market. Furthermore, the report includes market analysis by geography that depicts the most attractive and significant region in the global market in 2016.
The research methodology is a combination of primary and secondary research. Primary research includes information collected via e-mails, and telephonic interviews of key opinion leaders (KOL), and forms the bulk of our research. Secondary research includes information collected from various sources, by study of company websites, annual reports, stock analysis presentations, press releases, and various national and international databases.
Global Heparin Market: Segmentation
On the basis of product type global heparin market is segmented into unfractionated heparin (UFH), low-molecular weight heparin (LMWH), and ultra-low molecular weight heparin (ULMWH). On the basis of source heparin market is segmented into bovine and porcine. On the basis of formulation global heparin market is segmented into oral, and parenteral.


Based on geography, the global heparin market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report also consists of in-depth analysis for Muslim and Non-Muslim countries; Muslim countries such as GCC Countries, Morocco, Tunisia, Egypt, Turkey, Indonesia, Malaysia and Non-Muslim countries such as U.S., Canada, Germany, U.K., France, Italy, Spain, South Africa, China, India, Japan, Australia, Israel, Brazil, Mexico, Argentina, heparin market for products and source.
Global Heparin Market: Companies
The report also comprises list of major players in the market, their SWOT analysis, market share of these players in the heparin market, key business strategies, product portfolios, and recent developments. Key market players profiled in this report include Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Fresenius SE & Co. KGaA, Sanofi, Pfizer, Inc., LEO Pharma A/S, Aspen, Baxter International Inc., B. Braun Melsungen AG, and Syntex S.A.
The global heparin market has been segmented as follows:
Global Heparin Market by Product
  • Unfractionated Heparin
  • Low Molecular Weight Heparin (LMWH)
  • Ultra-low Molecular Weight Heparin (ULMWH)
Global Heparin Market by Source
  • Bovine
  • Porcine
Global Heparin Market by Formulation
  • Oral
  • Parenteral
Global Heparin Market by Geography
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Indonesia
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

Monday, 17 July 2017

2014 - 2022: Qualitative And Quantitative Analysis Of Heparin Market In Europe By Product Such As Unfractionated Heparin, Low Molecular Weight Heparin & Ultra Low Molecular Weight Heparin

Researchmoz added Most up-to-date research on "2014 - 2022: Qualitative And Quantitative Analysis Of Heparin Market In Europe By Product Such As Unfractionated Heparin, Low Molecular Weight Heparin & Ultra Low Molecular Weight Heparin" to its huge collection of research reports.

This report provides in-depth analysis of the heparin market in Europe. Stakeholders for this report include manufacturers of heparin products, crude heparin suppliers, heparin processing companies, and new players planning to enter the market.

The report provides qualitative and quantitative analysis of the heparin market in Europe. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information. Quantitative analysis includes market share held by companies in 2013, market size, and forecast for heparin product types across five major nations in Europe from 2012 to 2022. Market revenue is provided in terms of USD million from 2012 to 2022 along with the compound annual growth rate (CAGR %) from 2014 to 2022 for all the segments, considering 2013 as the base year. The executive summary of the report provides a snapshot of the heparin market in Europe with information on leading segments with respect to the market size, forecast value, market share of key players, growth rate (CAGR %) from 2014 to 2022, and growth factors. 

The market overview section comprises impact factors such as drivers, restraints, and opportunities for the heparin market in Europe. This factors would aid the stakeholders in establishing a strong foothold in the European heparin market. Furthermore, the market overview section comprises market attractiveness and value chain analysis. The market attractiveness analysis section provides a graphical view comparing the growth and market dynamics in different countries to identify the most attractive market for the period from 2014 to 2022. Value chain analysis offers detailed information on value addition activities in the manufacturing process of heparin-based pharmaceutical products.

Market share analysis is also provided in the market overview section of the report for the year 2013 in terms of value (%). Furthermore, the report analyzes different heparin product types such as unfractionated heparin, low molecular weight heparin, and ultra-low molecular weight heparin. The product type section provides market analysis for different types of heparin in Europe. This includes an overview of product types, indications for use, presence of any biosimilars, market drivers, issues, and regulations amended for its production and use. Prices of products vary based on product type and formulation. Formulations with different heparin concentrations and formulation type carry different prices across the countries in the European Union. Hence, the report provides average pricing analysis (based on the current prices) to offer an overview of prices of heparin-based pharmaceutical products in the EU.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=296897

The report further provides market analysis for heparin in five major countries in the EU: the U.K., Germany, France, Italy, and Spain. Market analysis for different heparin types is provided for each of these countries from 2012 to 2022 along with the CAGR from 2014 to 2022. The market has been estimated for finished heparin formulation and has not considered its APIs. Major factors such as aging population and increasing prevalence of venous thromboembolism (VTE) that propel the market for heparin in Europe are elaborated in the country-level analysis. This section also covers certain regulations governing the manufacture and import of heparin in some countries.

Major players operating in the heparin market in Europe such as Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Leo Pharma A/S, Pfizer, Inc., Sanofi S.A., and Syntex S.A. are profiled in this report. The report also provides important recommendations for these players and new entrants. These recommendations would enable the existing market players to expand their market share and help new companies establish their presence in the heparin market in Europe.

The Europe Heparin Market is segmented into the following categories: 

Europe Heparin Market, by Product
  • Unfractionated Heparin
  • Low Molecular Weight Heparin (LMWHs)
  • Ultra-low Molecular Weight Heparin (ULMWHs)
Europe Heparin Market, by Country
  • United Kingdom
  • Unfractionated Heparin
  • Low Molecular Weight Heparin (LMWHs)
  • Ultra-low Molecular Weight Heparin (ULMWHs)
  • Germany

Wednesday, 8 February 2017

At A CAGR Of 4.74%, Heparin Global Market Will Grow Over The Period 2017 - 2020

Researchmoz added Most up-to-date research on "At A CAGR Of 4.74%, Heparin Global Market Will Grow Over The Period 2017 - 2020" to its huge collection of research reports.

Heparin, a disaccharide anticoagulant or blood thinner, prevents the formation of blood clots. It is produced in the body by basophils and mast cells. It is stored within mast cells and secreted at the injury site. Though it has no effect on already formed clots, it enables the body's natural clot lysis mechanisms to dissolve clots. It can also be taken from outside as a drug. Heparin can be derived from natural sources such as pig intestine and bovine lungs. 

Heparin is divided into two types based on the fractionation process. Both types have medical use, with the selection done based on preference for a particular condition.

UFH: It is directly obtained from natural sources, without undergoing any fractionation.
LMWH: It is derived by depolymerizing UFH. The pharmacodynamics properties of LMWH are more predictable when compared to UFH.

Apart from these, another category of molecules, ULMWH are available. They are structurally related to LMWHs, but differ in the composition of monosaccharides and oligosaccharides. Therefore, they have different average molecular weights from LMWH.

Technavios analysts forecast the global heparin market to grow at a CAGR of 4.74% during the period 2016-2020.

Covered in this report 
The report covers the present scenario and the growth prospects of the global heparin market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generics used to treat disorders.

The market is divided into the following segments based on geography: 
Americas
APAC
EMEA

Technavio's report, Global Heparin Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
GlaxoSmithKline plc (GSK)
Leo Pharma A/S
Pfizer Inc.
Sanofi 

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=668428

Other prominent vendors 
Alchemi 
Baxter
BMS
Boehringer Ingelheim
Celgene 
Cosmo Pharmaceuticals
Dr.Reddy's Laboratories
Eisai 
Fresenius 
GSK

Market driver 
Growing prevalence of diseases
For a full, detailed list, view our report 

Market challenge 
Extensive use of generic products due to patent expirations
For a full, detailed list, view our report 

Market trend 
Expected exploitation of new therapeutic use 
For a full, detailed list, view our report 

Key questions answered in this report 
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors? 

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=668428